Adjusting for time-varying confounders in survival analysis using structural nested cumulative survival time models

Biometrics. 2020 Jun;76(2):472-483. doi: 10.1111/biom.13158. Epub 2019 Nov 7.

Abstract

Accounting for time-varying confounding when assessing the causal effects of time-varying exposures on survival time is challenging. Standard survival methods that incorporate time-varying confounders as covariates generally yield biased effect estimates. Estimators using weighting by inverse probability of exposure can be unstable when confounders are highly predictive of exposure or the exposure is continuous. Structural nested accelerated failure time models (AFTMs) require artificial recensoring, which can cause estimation difficulties. Here, we introduce the structural nested cumulative survival time model (SNCSTM). This model assumes that intervening to set exposure at time t to zero has an additive effect on the subsequent conditional hazard given exposure and confounder histories when all subsequent exposures have already been set to zero. We show how to fit it using standard software for generalized linear models and describe two more efficient, double robust, closed-form estimators. All three estimators avoid the artificial recensoring of AFTMs and the instability of estimators that use weighting by the inverse probability of exposure. We examine the performance of our estimators using a simulation study and illustrate their use on data from the UK Cystic Fibrosis Registry. The SNCSTM is compared with a recently proposed structural nested cumulative failure time model, and several advantages of the former are identified.

Keywords: Aalen's additive model; G-estimation; accelerated failure time model; marginal structural model; survival data.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biometry
  • Computer Simulation
  • Confidence Intervals
  • Confounding Factors, Epidemiologic
  • Cystic Fibrosis / drug therapy
  • Cystic Fibrosis / mortality
  • Deoxyribonucleases / therapeutic use
  • Humans
  • Linear Models
  • Models, Statistical*
  • Proportional Hazards Models
  • Registries / statistics & numerical data
  • Survival Analysis*
  • Time Factors
  • United Kingdom / epidemiology

Substances

  • Deoxyribonucleases